1. Home
  2. WLFC vs SVRA Comparison

WLFC vs SVRA Comparison

Compare WLFC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

HOLD

Current Price

$54.89

Market Cap

1.2B

ML Signal

HOLD

Logo Savara Inc.

SVRA

Savara Inc.

HOLD

Current Price

$5.30

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLFC
SVRA
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1997
2009

Fundamental Metrics

Financial Performance
Metric
WLFC
SVRA
Price
$54.89
$5.30
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$160.00
$7.33
AVG Volume (30 Days)
139.9K
1.2M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
0.86%
N/A
EPS Growth
N/A
N/A
EPS
2.39
N/A
Revenue
$569,223,000.00
N/A
Revenue This Year
$2.75
N/A
Revenue Next Year
$7.35
$430.87
P/E Ratio
$22.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$52.13
$3.34
52 Week High
$244.62
$7.01

Technical Indicators

Market Signals
Indicator
WLFC
SVRA
Relative Strength Index (RSI) 32.78 49.73
Support Level $52.78 $5.16
Resistance Level $60.00 $5.48
Average True Range (ATR) 1.59 0.19
MACD 2.22 0.01
Stochastic Oscillator 36.93 58.10

Price Performance

Historical Comparison
WLFC
SVRA

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: